Sangamo BioSciences (SGMO) Partner Pfizer Announced Hemophilia-A Clinical Hold Lifted, 'A Clear Positive for SGMO' - RBC
Tweet Send to a Friend
RBC Capital analyst Luca Issi weighed in on Sangamo BioSciences (NASDAQ: SGMO) after partner Pfizer announced this morning that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
